These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2783840)

  • 1. Implantation of a recurrent laryngeal nerve stimulator for the treatment of spastic dysphonia.
    Friedman M; Toriumi DM; Grybauskas VT; Applebaum EL
    Ann Otol Rhinol Laryngol; 1989 Feb; 98(2):130-4. PubMed ID: 2783840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of spastic dysphonia without nerve section.
    Friedman M; Toriumi DM; Grybauskas V; Applebaum EL
    Ann Otol Rhinol Laryngol; 1987; 96(5):590-6. PubMed ID: 3499837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofeedback therapy for spastic dysphonia.
    Watanabe H; Komiyama S; Ryu S; Kannae S; Matsubara H
    Auris Nasus Larynx; 1982; 9(3):183-90. PubMed ID: 7168715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and tolerability of the implantable recurrent laryngeal nerve stimulator.
    Friedman M; Wernicke JF; Caldarelli DD
    Laryngoscope; 1994 Oct; 104(10):1240-4. PubMed ID: 7934595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Closed-Loop Stimulator for Laryngeal Reanimation: Part 2. Device Testing in the Canine Model of Laryngeal Paralysis.
    Heaton JT; Kobler JB; Otten DM; Hillman RE; Zeitels SM
    Ann Otol Rhinol Laryngol; 2019 Mar; 128(3_suppl):53S-70S. PubMed ID: 30843434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting the side of recurrent laryngeal nerve section for spastic dysphonia.
    Izdebski K; Dedo HH
    Otolaryngol Head Neck Surg; 1981; 89(3 Pt 1):423-6. PubMed ID: 6791104
    [No Abstract]   [Full Text] [Related]  

  • 7. Artificial manipulation of voice in the human by an implanted stimulator.
    Broniatowski M; Grundfest-Broniatowski S; Zobenica NS; Tyler DJ
    Laryngoscope; 2008 Oct; 118(10):1889-93. PubMed ID: 18758384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vivo canine model for testing treatment effects in laryngeal hyperadduction disorders.
    Green DC; Berke GS
    Laryngoscope; 1990 Nov; 100(11):1229-35. PubMed ID: 2233089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective section of the recurrent laryngeal nerve for the treatment of spastic dysphonia: an experimental study and preliminary clinical report.
    Carpenter RJ; Snyder GG; Henley-Cohn JL
    Otolaryngol Head Neck Surg; 1981; 89(6):986-91. PubMed ID: 6801603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procedures for the selection of spastic dysphonia patients for recurrent laryngeal nerve section.
    Ludlow CL; Naunton RF; Bassich CJ
    Otolaryngol Head Neck Surg; 1984 Feb; 92(1):24-31. PubMed ID: 6422412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The present status of adductor spastic dysphonia.
    Stoicheff ML
    J Otolaryngol; 1983 Oct; 12(5):311-4. PubMed ID: 6644860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
    Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
    J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent laryngeal nerve section for spastic dysphonia.
    Dedo HH
    Ann Otol Rhinol Laryngol; 1976; 85(4 Pt 1):451-9. PubMed ID: 949152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous electrical stimulation of laryngeal muscles: an alternative for enhancing recovery of unilateral recurrent laryngeal nerve paralysis.
    Garcia Perez A; Hernández López X; Valadez Jiménez VM; Minor Martínez A; Ysunza PA
    J Voice; 2014 Jul; 28(4):524.e1-7. PubMed ID: 24726329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate results of 306 recurrent laryngeal nerve sections for spastic dysphonia.
    Dedo HH; Izdebski K
    Laryngoscope; 1983 Jan; 93(1):9-16. PubMed ID: 6823180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of laryngeal complications in patients implanted with the Cyberonics vagal nerve stimulator.
    Shaw GY; Sechtem P; Searl J; Dowdy ES
    Ann Otol Rhinol Laryngol; 2006 Apr; 115(4):260-7. PubMed ID: 16676822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and treatment of recurrent spasticity after recurrent laryngeal nerve section. A preliminary report.
    Dedo HH; Izdebski K
    Ann Otol Rhinol Laryngol; 1984; 93(4 Pt 1):343-5. PubMed ID: 6465774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
    Sulica L; Blitzer A; Brin MF; Stewart CF
    Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems with surgical (RLN section) treatment of spastic dysphonia.
    Dedo HH; Izdebski K
    Laryngoscope; 1983 Mar; 93(3):268-71. PubMed ID: 6834947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional evaluation of ansa cervicalis nerve transfer for unilateral vocal cord paralysis: future directions for laryngeal reinnervation.
    Green DC; Berke GS; Graves MC
    Otolaryngol Head Neck Surg; 1991 Apr; 104(4):453-66. PubMed ID: 1903856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.